Education
About Us
Working with TipRanks
Follow Us
Abingdon Health PLC (GB:ABDX)
:ABDX
RESEARCH TOOLSreports
ABDX Stock Chart & Stats
Day’s Range― - ―
52-Week Range5.50p - 10.50p
Previous CloseN/A
Volume7.61K
Average Volume (3M)91.30K
Market Cap
£12.51M
Enterprise Value24.82M
Total Cash (Recent Filing)£3.67M
Total Debt (Recent Filing)£1.01M
Price to Earnings (P/E)―
Beta-0.09
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding193,630,810
10 Day Avg. Volume162,594
30 Day Avg. Volume91,297
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£7.50Price Target Upside15.38% Upside
Rating ConsensusHold
Number of Analyst Covering0
Abingdon Health PLC News
ABDX FAQ
What was Abingdon Health PLC’s price range in the past 12 months?
Abingdon Health PLC lowest share price was 5.50p and its highest was 10.50p in the past 12 months.
What is Abingdon Health PLC’s market cap?
Abingdon Health PLC’s market cap is £12.51M.
When is Abingdon Health PLC’s upcoming earnings report date?
Abingdon Health PLC’s upcoming earnings report date is Nov 13, 2025 which is in 97 days.
How were Abingdon Health PLC’s earnings last quarter?
Currently, no data Available
Is Abingdon Health PLC overvalued?
According to Wall Street analysts Abingdon Health PLC’s price is currently Undervalued.
Does Abingdon Health PLC pay dividends?
Abingdon Health PLC does not currently pay dividends.
What is Abingdon Health PLC’s EPS estimate?
Abingdon Health PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abingdon Health PLC have?
Abingdon Health PLC has 193,630,810 shares outstanding.
What happened to Abingdon Health PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Abingdon Health PLC?
Currently, no hedge funds are holding shares in GB:ABDX
Company Description
Abingdon Health PLC
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Abingdon Health PLC (ABDX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.